SCHEMBL2496469

SCHEMBL2496469

O=C1Nc2cccc(Cl)c2C1(O)c1cccc2c1OCO2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 1/20 0.38
MTOR P42345 1/20 0.36
RICTOR Q6R327 1/20 0.36
RPTOR Q8N122 1/20 0.36
MAPKAP1 Q9BPZ7 1/20 0.36
MLST8 Q9BVC4 1/20 0.36
MT-CO2 P00403 1/20 0.35
ALDH1A1 P00352 3/20 0.33
CYP3A4 P08684 2/20 0.33
AKR1B1 P15121 1/20 0.33
CYP2D6 P10635 1/20 0.33
GAA P10253 3/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2498220 0.81 MDM2 (0.38) GSK3BKMT2AMEN1MTORRICTOR
SCHEMBL2492740 0.81 IDO1 (0.41) KMT2AMEN1MTORRICTORRPTOR
SCHEMBL384666 0.81 KMT2A (0.43) KMT2AMEN1MTORRICTORRPTOR
SCHEMBL2496973 0.77 L3MBTL1 (0.52) KMT2AMEN1MTORRICTORRPTOR
SCHEMBL2492745 0.77 ALDH1A1 (0.38) GSK3BKMT2AMEN1MTORRICTOR
SCHEMBL2496712 0.77 SMN1; SMN2 (0.44) GSK3BKMT2AMEN1MTORRICTOR
SCHEMBL2492868 0.77 ALDH1A1 (0.53) KMT2AMEN1MTORRICTORRPTOR
SCHEMBL2496902 0.74 PGR (0.40) GSK3BKMT2AMEN1MTORRICTOR
SCHEMBL2501554 0.73 ALPL (0.47) KMT2AMEN1ALDH1A1CYP3A4AKR1B1
SCHEMBL4590635 0.70 PGR (0.39) GSK3BKMT2AMEN1GAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 GSK3B 1973/4885KMT2A 1662/4885MEN1 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.